Health Canada drug identification number

DIN 02539888 — LIVMARLI 9.5 MG

LIVMARLI is a solution of Maralixibat marketed by MIRUM PHARMACEUTICALS, INC.. The full Maralixibat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02539888
Brand name
LIVMARLI
Active ingredient
Maralixibat
Strength
9.5 MG
Dosage form
SOLUTION
Route
ORAL
Manufacturer
MIRUM PHARMACEUTICALS, INC.
Health Canada status
MARKETED
Drug class
Ileal bile acid transporter (IBAT) inhibitor

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Maralixibat products

DINBrandStrengthFormManufacturerStatus
02565234 LIVMARLI 10 MG TABLET MIRUM PHARMACEUTICALS, INC. MARKETED
02565242 LIVMARLI 15 MG TABLET MIRUM PHARMACEUTICALS, INC. MARKETED
02565277 LIVMARLI 19 MG SOLUTION MIRUM PHARMACEUTICALS, INC. MARKETED
02565250 LIVMARLI 20 MG TABLET MIRUM PHARMACEUTICALS, INC. MARKETED
02565269 LIVMARLI 30 MG TABLET MIRUM PHARMACEUTICALS, INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.